HomeAuthorsPosts by admin

admin

1863 POSTS6 COMMENTS

Latest Pharma-News

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval

admin - March 27, 2023 0

Latest Pharma-News

Sandoz receives US FDA approval for biosimilar Hyrimoz® high-concentration formulation

admin - March 24, 2023 0

Latest Pharma-News

Calquence granted first regulatory approval in China for adults with previously treated mantle cell lymphoma

admin - March 24, 2023 0

Latest Pharma-News

Bayer’s Nubeqa™ approved for additional prostate cancer indication in China

admin - March 21, 2023 0

Latest Pharma-News

FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products

admin - March 21, 2023 0

Latest Pharma-News

Pfizer’s XTANDI® plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer

admin - March 20, 2023 0

Latest Pharma-News

FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products

admin - March 20, 2023 0

Latest Pharma-News

Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments

admin - March 17, 2023 0

Latest Pharma-News

FDA Authorizes Copenhagen Classic Snuff to be Marketed as a Modified Risk Tobacco Product

admin - March 17, 2023 0

Latest Pharma-News

Sanofi to acquire Provention Bio, adding to portfolio TZIELD for type diabetes (T1D)

admin - March 14, 2023 0

Latest Pharma-News

LEO Pharma and ICON enter a Strategic Partnership on clinical trial mission

admin - March 13, 2023 0

Latest Pharma-News

AstraZeneca launches call for entries to 2023 global R&D Postdoctoral Challenge

admin - March 13, 2023 0

1...456...156 Page 5 of 156

TOP AUTHORS

admin

1863 POSTS6 COMMENTS

OIdMIHuOdiu

0 POSTS0 COMMENTS

tintin

0 POSTS0 COMMENTS

First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease

January 18, 2025

Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer

January 18, 2025

What is Decentralized clinical trials?:Benefits and challenges of implementing DCT

September 23, 2024

FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US

March 8, 2024

admin

TOP AUTHORS

Most Read

First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease

Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer

What is Decentralized clinical trials?:Benefits and challenges of implementing DCT

FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

CRASH COURSE ON CLINICAL DATA MANAGEMENT

Interview Questions on Institutional Review Board(IRB)

POPULAR POSTS

How to Find Paid Clinical Trials Near You

What Is CDISC and What Are CDISC Data Standards?

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

POPULAR CATEGORY

ABOUT US

FOLLOW US